Skip to main content
. 2014 Aug 22;141(2):323–331. doi: 10.1007/s00432-014-1800-6

Fig. 1.

Fig. 1

Funnel plots using response rates as an outcome for a, b thymoma and cf thymic carcinoma in each chemotherapy category (anthracycline-based vs. non-anthracycline-based and cisplatin-based vs. carboplatin-based)